← Back to Search

Adipose Tissue Processing Device

SyntrFuge™ Processed Fat Grafting for Facial Atrophy

N/A
Waitlist Available
Research Sponsored by Syntr Health Technologies, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial is testing whether fat processed with the SyntrFuge system can be used for facial aesthetics and contouring. If successful, the fat will be injected into the treatment sites.

Who is the study for?
This trial is for adults aged 18-70 seeking facial fat grafting without severe allergies, uncontrolled diseases, or recent cosmetic procedures in the area. Participants must not be pregnant or planning pregnancy and should avoid other facial treatments during the study.Check my eligibility
What is being tested?
The SyntrFuge™ System is being tested for its effectiveness in processing adipose tissue for improving facial aesthetics. Patients will receive injections of their own processed fat into targeted areas of their face.See study design
What are the potential side effects?
Potential side effects may include reactions at the injection site such as redness, swelling, pain, bruising, infection risk and possibly allergic responses to the injected material.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
FaceQ Satisfaction surveys
Secondary outcome measures
Global Aesthetic Improvement Scale (GAIS)
Investigator's Satisfaction Scale

Trial Design

1Treatment groups
Experimental Treatment
Group I: SyntrFuge SystemExperimental Treatment1 Intervention
Adipose tissue microsized via the SyntrFuge System

Find a Location

Who is running the clinical trial?

Syntr Health Technologies, Inc.Lead Sponsor
2 Previous Clinical Trials
236 Total Patients Enrolled

Media Library

SyntrFuge System (Adipose Tissue Processing Device) Clinical Trial Eligibility Overview. Trial Name: NCT05522426 — N/A
Facial Atrophy Research Study Groups: SyntrFuge System
Facial Atrophy Clinical Trial 2023: SyntrFuge System Highlights & Side Effects. Trial Name: NCT05522426 — N/A
SyntrFuge System (Adipose Tissue Processing Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05522426 — N/A
~17 spots leftby Jun 2025